These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 10097404)

  • 41. Possible incorporation of petroleum-based carbons in biochemicals produced by bioprocess--biomass carbon ratio measured by accelerator mass spectrometry.
    Kunioka M
    Appl Microbiol Biotechnol; 2010 Jun; 87(2):491-7. PubMed ID: 20454790
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Accelerator mass spectrometry best practices for accuracy and precision in bioanalytical (14)C measurements.
    Vogel JS; Giacomo JA; Schulze-König T; Keck BD; Lohstroh P; Dueker S
    Bioanalysis; 2010 Mar; 2(3):455-68. PubMed ID: 21083255
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Accelerator mass spectrometry in biomedical dosimetry: relationship between low-level exposure and covalent binding of heterocyclic amine carcinogens to DNA.
    Turteltaub KW; Felton JS; Gledhill BL; Vogel JS; Southon JR; Caffee MW; Finkel RC; Nelson DE; Proctor ID; Davis JC
    Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5288-92. PubMed ID: 2371271
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Measurement of beryllium in biological samples by accelerator mass spectrometry: applications for studying chronic beryllium disease.
    Chiarappa-Zucca ML; Finkel RC; Martinelli RE; McAninch JE; Nelson DO; Turteltaub KW
    Chem Res Toxicol; 2004 Dec; 17(12):1614-20. PubMed ID: 15606137
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Addressing metabolite safety during first-in-man studies using ¹⁴C-labeled drug and accelerator mass spectrometry.
    Lappin G; Seymour M
    Bioanalysis; 2010 Jul; 2(7):1315-24. PubMed ID: 21083242
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Applications of low-abundance-radioisotope measurements with accelerator mass spectrometry to the biomedical sciences].
    Nakamura T
    Tanpakushitsu Kakusan Koso; 1994 Aug; 39(11):2011-20. PubMed ID: 7938599
    [No Abstract]   [Full Text] [Related]  

  • 47. Accelerator mass spectrometry for quantitative in vivo tracing.
    Vogel JS
    Biotechniques; 2005 Jun; Suppl():25-9. PubMed ID: 16528913
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Dating and measurements of radioactive isotopes with accelerator mass spectrometry].
    Nakai N; Nakamura T
    Radioisotopes; 1983 Dec; 32(12):645-55. PubMed ID: 6374773
    [No Abstract]   [Full Text] [Related]  

  • 49. (3)He mass spectrometry for very low-level measurement of organic tritium in environmental samples.
    Jean-Baptiste P; Fourré E; Dapoigny A; Baumier D; Baglan N; Alanic G
    J Environ Radioact; 2010 Feb; 101(2):185-90. PubMed ID: 19906472
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Accelerator mass spectrometry allows for cellular quantification of doxorubicin at femtomolar concentrations.
    DeGregorio MW; Dingley KH; Wurz GT; Ubick E; Turteltaub KW
    Cancer Chemother Pharmacol; 2006 Feb; 57(3):335-42. PubMed ID: 16047147
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Issues and opportunities in accelerator mass spectrometry for stable isotopes.
    Matteson S
    Mass Spectrom Rev; 2008; 27(5):470-84. PubMed ID: 18553556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of microdosing strategies for studies in preclinical drug development: demonstration of linear pharmacokinetics in dogs of a nucleoside analog over a 50-fold dose range.
    Sandhu P; Vogel JS; Rose MJ; Ubick EA; Brunner JE; Wallace MA; Adelsberger JK; Baker MP; Henderson PT; Pearson PG; Baillie TA
    Drug Metab Dispos; 2004 Nov; 32(11):1254-9. PubMed ID: 15286054
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microdose study of 14C-acetaminophen with accelerator mass spectrometry to examine pharmacokinetics of parent drug and metabolites in healthy subjects.
    Tozuka Z; Kusuhara H; Nozawa K; Hamabe Y; Ikushima I; Ikeda T; Sugiyama Y
    Clin Pharmacol Ther; 2010 Dec; 88(6):824-30. PubMed ID: 21048707
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early human ADME using microdoses and microtracers: bioanalytical considerations.
    Dueker SR; Lohstroh PN; Giacomo JA; Le TV; Keck BD; Vogel JS
    Bioanalysis; 2010 Mar; 2(3):441-54. PubMed ID: 21083254
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biological accelerator mass spectrometry at Uppsala University.
    Salehpour M; Possnert G; Bryhni H; Palminger-Hallén I; Ståhle L
    Appl Radiat Isot; 2009 Mar; 67(3):495-9. PubMed ID: 18789710
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ultra-low-level determination of (236)U in IAEA marine reference materials by ICPMS and AMS.
    Lee SH; Povinec PP; Wyse E; Hotchkis MA
    Appl Radiat Isot; 2008; 66(6-7):823-8. PubMed ID: 18343143
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ultrasensitive radioisotope, stable-isotope, and trace-element analysis in the biological sciences using tandem accelerator mass spectrometry.
    Elmore D
    Biol Trace Elem Res; 1987 Apr; 12(1):231-45. PubMed ID: 24254606
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Automated combustion accelerator mass spectrometry for the analysis of biomedical samples in the low attomole range.
    van Duijn E; Sandman H; Grossouw D; Mocking JA; Coulier L; Vaes WH
    Anal Chem; 2014 Aug; 86(15):7635-41. PubMed ID: 25033319
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analytical techniques in biomedical stable isotope applications: (isotope ratio) mass spectrometry or infrared spectrometry?
    Stellaard F; Elzinga H
    Isotopes Environ Health Stud; 2005 Dec; 41(4):345-61. PubMed ID: 16543190
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS.
    Xu RN; Fan L; Rieser MJ; El-Shourbagy TA
    J Pharm Biomed Anal; 2007 Jun; 44(2):342-55. PubMed ID: 17360141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.